메뉴 건너뛰기




Volumn 6, Issue 6, 1999, Pages 488-491

Successful psychotropic management of drug related psychosis in Parkinson's Disease

Author keywords

Drugs; Parkinson's disease; Psychotic symptoms

Indexed keywords


EID: 7644221906     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(99)90006-1     Document Type: Article
Times cited : (1)

References (25)
  • 1
    • 0025766667 scopus 로고
    • The Management of the Levodopa Psychoses
    • Friedman J. The Management of the Levodopa Psychoses. Clin Neuropharmacol 1991; 14: 283-294.
    • (1991) Clin Neuropharmacol , vol.14 , pp. 283-294
    • Friedman, J.1
  • 3
    • 0027761975 scopus 로고
    • Neuropsychological and psychiatric side effects in the treatment of Parkinsons's Disease
    • Saint-Cyr J, Taylor A, Lang A. Neuropsychological and psychiatric side effects in the treatment of Parkinsons's Disease. Neurology 1993; 43 (Suppl): S47-S53.
    • (1993) Neurology , vol.43 , Issue.SUPPL.
    • Saint-Cyr, J.1    Taylor, A.2    Lang, A.3
  • 5
    • 0027398865 scopus 로고
    • Ondansetron for hallucinosis in advanced Parkinson's disease
    • Zoldan J, Friedberg G, Goldberg-Stern H, Melamed E. Ondansetron for hallucinosis in advanced Parkinson's disease. [letter] Lancet 1993; 341: 562-563.
    • (1993) Lancet , vol.341 , pp. 562-563
    • Zoldan, J.1    Friedberg, G.2    Goldberg-Stern, H.3    Melamed, E.4
  • 6
    • 0029161630 scopus 로고
    • Psychosis in advanced Parkinson's disease: Treatment with ondansetron, a 5-HT receptor antagonist
    • Zoldan J, Friedberg G, Livneh M, Melamed E. Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT receptor antagonist. Neurology 1995; 45: 1305-1308.
    • (1995) Neurology , vol.45 , pp. 1305-1308
    • Zoldan, J.1    Friedberg, G.2    Livneh, M.3    Melamed, E.4
  • 7
    • 0028213564 scopus 로고
    • Clozapine: A 2-year open trial in Parkinson's disease patients with psychosis
    • Factor S, Brown D, Molho E, Podskalny D. Clozapine: A 2-year open trial in Parkinson's disease patients with psychosis. Neurology 1994; 44: 544-546.
    • (1994) Neurology , vol.44 , pp. 544-546
    • Factor, S.1    Brown, D.2    Molho, E.3    Podskalny, D.4
  • 8
    • 0029064499 scopus 로고
    • Low-dose clozapine in the treatment of levodopa induced mental disturbances in Parkinson's disease
    • Rabey J, Treves T, Neufeld M, Orlov E, Korczyn A. Low-dose clozapine in the treatment of levodopa induced mental disturbances in Parkinson's disease. Neurology 1995; 45: 1699-1701.
    • (1995) Neurology , vol.45 , pp. 1699-1701
    • Rabey, J.1    Treves, T.2    Neufeld, M.3    Orlov, E.4    Korczyn, A.5
  • 9
    • 0024418579 scopus 로고
    • Clozapine in the treatment of psychosis in Parkinson's disease
    • Friedman J, Lannon M. Clozapine in the treatment of psychosis in Parkinson's disease. Neurology 1989; 39: 1219-1221.
    • (1989) Neurology , vol.39 , pp. 1219-1221
    • Friedman, J.1    Lannon, M.2
  • 10
    • 0028144914 scopus 로고
    • Risperidone in Parkinson's disease
    • 10
    • Ford B, Lynch T, Greene P. Risperidone in Parkinson's disease. [letter] Lancet 1994; 344: 681. 10
    • (1994) Lancet , vol.344 , pp. 681
    • Ford, B.1    Lynch, T.2    Greene, P.3
  • 11
    • 0029845563 scopus 로고    scopus 로고
    • Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
    • Wolters E, Jansen E, Tuynman-Qua H, Bergmans P. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease. Neurology 1996; 47: 1085-1087.
    • (1996) Neurology , vol.47 , pp. 1085-1087
    • Wolters, E.1    Jansen, E.2    Tuynman-Qua, H.3    Bergmans, P.4
  • 12
    • 0023698509 scopus 로고
    • Clozapine treatment of drug-induced psychotic symptoms in late stages of Parkinson's disease
    • Ostergaard K, Dupont E. Clozapine treatment of drug-induced psychotic symptoms in late stages of Parkinson's disease, [letter] Acta Neurol Scand 1988: 78: 349-350.
    • (1988) Acta Neurol Scand , vol.78 , pp. 349-350
    • Ostergaard, K.1    Dupont, E.2
  • 13
    • 0026000655 scopus 로고
    • Clozapine is beneficial for psychosis in Parkinson's disease
    • Kahn N, Freeman A, Juncos J, Manning M, Watts R. Clozapine is beneficial for psychosis in Parkinson's disease. Neurology 1991; 41: 1699-1701.
    • (1991) Neurology , vol.41 , pp. 1699-1701
    • Kahn, N.1    Freeman, A.2    Juncos, J.3    Manning, M.4    Watts, R.5
  • 14
    • 0028356138 scopus 로고
    • Risperidone for hallucinations in levodopa treated Parkinson's disease patients
    • Meco A, Bonifati V, Giustini P. Risperidone for hallucinations in levodopa treated Parkinson's disease patients. [letter] Lancet 1994; 343: 1370-1371.
    • (1994) Lancet , vol.343 , pp. 1370-1371
    • Meco, A.1    Bonifati, V.2    Giustini, P.3
  • 15
    • 0001991792 scopus 로고
    • Health Accounting - Functional Assessment of the Long Term Patient
    • Kottke, Stilwell, Lehmann. (Editors). London: W.B. Saunders Company
    • Granger CV. Health Accounting - Functional Assessment of the Long Term Patient. In: Kottke, Stilwell, Lehmann. (Editors). Kruzen's Handbook of Physical Medicine and Rehabilitation, 3rd Edition. London: W.B. Saunders Company, 1982; 263.
    • (1982) Kruzen's Handbook of Physical Medicine and Rehabilitation, 3rd Edition , pp. 263
    • Granger, C.V.1
  • 16
    • 0016823810 scopus 로고
    • 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician
    • Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12: 189-198.
    • (1975) J Psychiat Res , vol.12 , pp. 189-198
    • Folstein, M.F.1    Folstein, S.E.2    McHugh, P.R.3
  • 17
    • 0014261678 scopus 로고
    • Critical Analysis of the Disability in Parkinson's Disease
    • Webster DP. Critical Analysis of the Disability in Parkinson's Disease. Modern Treatment 1968; 5: 257-282.
    • (1968) Modern Treatment , vol.5 , pp. 257-282
    • Webster, D.P.1
  • 18
    • 0026055127 scopus 로고
    • New Antipsychoptics: Classification, Efficacy and Adverse effects
    • Gerlach J. New Antipsychoptics: Classification, Efficacy and Adverse effects. Schizophrenia Bulletin 1986; 17: 289-309.
    • (1986) Schizophrenia Bulletin , vol.17 , pp. 289-309
    • Gerlach, J.1
  • 19
    • 0020079689 scopus 로고
    • Pharmacology of hallucinations induced by long-term drug therapy
    • Goetz C, Tanner C, Klauwans H. Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry 1982; 139: 494-497.
    • (1982) Am J Psychiatry , vol.139 , pp. 494-497
    • Goetz, C.1    Tanner, C.2    Klauwans, H.3
  • 20
    • 0028943721 scopus 로고
    • Risperidone in Parkinson's Disease
    • Tavares A. Risperidone in Parkinson's Disease. [letter] J Neurol Neurosurg Psychiatry 1995; 58: 521.
    • (1995) J Neurol Neurosurg Psychiatry , vol.58 , pp. 521
    • Tavares, A.1
  • 21
    • 0022492837 scopus 로고
    • Performance deficit induced by low doses of dopamine agonists in rats toward a model for approaching the neurobiology of negative schizophrenic symptomology
    • Carnoy P, Soubrie P, Puech AJ et al. Performance deficit induced by low doses of dopamine agonists in rats toward a model for approaching the neurobiology of negative schizophrenic symptomology. Biological Psychiatry 1986; 21: 11-22.
    • (1986) Biological Psychiatry , vol.21 , pp. 11-22
    • Carnoy, P.1    Soubrie, P.2    Puech, A.J.3
  • 22
    • 0022552703 scopus 로고
    • Differential modulation of dopamine D2 Receptors by chronic Haloperidol, Nitrendipine and Pimozide
    • Tecott LH, Kwong LL, Uhr S et al. Differential modulation of dopamine D2 Receptors by chronic Haloperidol, Nitrendipine and Pimozide. Biological Psychiatry 1986; 21: 1114-1122.
    • (1986) Biological Psychiatry , vol.21 , pp. 1114-1122
    • Tecott, L.H.1    Kwong, L.L.2    Uhr, S.3
  • 23
  • 24
    • 0030944923 scopus 로고    scopus 로고
    • Olanzepine: A novel atypical neuroleptic agent
    • Reuss VI. Olanzepine: A novel atypical neuroleptic agent. Lancet 1997; 349: 1264-1265.
    • (1997) Lancet , vol.349 , pp. 1264-1265
    • Reuss, V.I.1
  • 25
    • 84920344380 scopus 로고    scopus 로고
    • Mims August/September 1998
    • Mims August/September 1998


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.